APP and Alzheimer disease: In postmortem entorhinal cortex of AD patients, increased levels of ChE (1.7-fold, p = 0.027) were also observed, although the predominantly increased species was different between AD humans (16:1ChE, 16:0ChE and 18:1ChE) and mice with mutated APP (22:6ChE) [9].